Starling Oncology, Inc. (STLNW) stock
STLNWNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as DFPH, STLN
$0.03+0.00 (+10.87%)
Close on Oct 30, 2026Market cap $665.51MP/E –Yield –
Starling Oncology operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Starling Oncology's operating cash flow for the twelve months ending Jun 30, 2026 was $328.00K. For fiscal 2025 it was -$24.59M. The highest annual figure on record is $508.00K in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$24.59M | – |
| FY2024 | Dec 31, 2024 | -$26.54M | – |
| FY2023 | Dec 31, 2023 | -$36.32M | – |
| FY2022 | Dec 31, 2022 | -$61.76M | – |
| FY2021 | Dec 31, 2021 | -$32.68M | -6533.1% |
| FY2020 | Dec 31, 2020 | $508.00K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $11.94M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.22M | – |
| Q4 FY2025 | Dec 31, 2025 | $3.23M | -19.2% |
| Q3 FY2025 | Sep 30, 2025 | -$12.63M | -1642.1% |
| Q2 FY2025 | Jun 30, 2025 | -$10.20M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.99M | – |
| Q4 FY2024 | Dec 31, 2024 | $4.00M | – |
| Q3 FY2024 | Sep 30, 2024 | $819.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$15.66M | – |
| Q1 FY2024 | Mar 31, 2024 | -$15.88M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.89M | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.31M | – |
| Q2 FY2023 | Jun 30, 2023 | -$8.66M | – |
| Q1 FY2023 | Mar 31, 2023 | -$15.45M | – |
| Q4 FY2022 | Dec 31, 2022 | -$14.00M | – |
| Q3 FY2022 | Sep 30, 2022 | -$20.40M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.38M | – |
| Q1 FY2022 | Mar 31, 2022 | -$16.98M | -3759.7% |
| Q4 FY2021 | Dec 31, 2021 | -$23.34M | -2412.8% |
| Q3 FY2021 | Sep 30, 2021 | -$2.68M | – |
| Q2 FY2021 | Jun 30, 2021 | -$7.13M | – |
| Q1 FY2021 | Mar 31, 2021 | $464.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $1.01M | – |
| Q3 FY2020 | Sep 30, 2020 | -$69.42K | – |
| Q2 FY2020 | Jun 30, 2020 | -$402.77K | – |
| Q1 FY2020 | Mar 31, 2020 | -$28.75K | – |